-
(2R,3R)-2,3-dihydroxybutanedioic acid; 1-methyl-2-[(E)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine
-
ChemBase ID:
133130
-
Molecular Formular:
C15H20N2O6S
-
Molecular Mass:
356.3941
-
Monoisotopic Mass:
356.10420737
-
SMILES and InChIs
SMILES:
CN1CCCN=C1/C=C/c1cccs1.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
Canonical SMILES:
OC(=O)[C@@H]([C@H](C(=O)O)O)O.CN1CCCN=C1/C=C/c1cccs1
InChI:
InChI=1S/C11H14N2S.C4H6O6/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10;5-1(3(7)8)2(6)4(9)10/h2,4-6,9H,3,7-8H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/b6-5+;/t;1-,2-/m.1/s1
InChIKey:
VWRCYAZJKNPEQR-NIEARKAZSA-N
-
Cite this record
CBID:133130 http://www.chembase.cn/molecule-133130.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2R,3R)-2,3-dihydroxybutanedioic acid; 1-methyl-2-[(E)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine
|
|
|
IUPAC Traditional name
|
L(+)-tartaric acid; pyrantel
|
|
|
Synonyms
|
1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine
|
Pyrantel (+)-tartrate salt
|
Pyrantel tartrate salt
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Acceptors
|
2
|
H Donor
|
0
|
LogD (pH = 5.5)
|
-0.45122287
|
LogD (pH = 7.4)
|
-0.40053108
|
Log P
|
1.9635495
|
Molar Refractivity
|
61.8136 cm3
|
Polarizability
|
22.833937 Å3
|
Polar Surface Area
|
15.6 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P7674
|
Application Pyrantel is used to study neuronal nicotinic receptors and has been is used to treat parasiticinfections in livestock1. Pyrantel tartrate salt is used to study allosteric modulation of the neuronal nicotinic acetylcholine receptors (nAChRs)2. Biochem/physiol Actions Pyrantel is a nematode muscle cell-associated nicotinic agonist for the acetylcholine (ACh) receptor. Cholinesterase inhibitor. Pyrantel is a nematode muscle cell-associated nicotinic agonist for the acetylcholine (ACh) receptor. This is a cholinesterase inhibitor. It causes spastic muscle paralysis in parasitic worms due to prolonged activation of the excitatory nicotinic acetylcholine (nACh) receptors. |
PATENTS
PATENTS
PubChem Patent
Google Patent